AIDS

1. CHERKOS AS, Cranmer LM, Njuguna I, LaCourse SM, et al
   Effect of TB-HIV co-treatment on clinical and growth outcomes among hospitalized children newly initiating antiretroviral therapy.
   AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003797.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

2. LAUFER N, Bouzas MB, Fernandez-Giuliano S, Zapiola I, et al
   Pretreatment HIV-1 Resistance in Argentina: results from the second surveillance study following WHO guidelines (2019).
   AIDS Res Hum Retroviruses. 2024 Feb 22. doi: 10.1089/AID.2023.0083.
   

   >> Share

   
   

   
   Ann Intern Med

3. 
   Correction: SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy.
   Ann Intern Med. 2024 Feb 20. doi: 10.7326/L24-0045.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

4. MULATO A, Lansdon E, Aoyama R, Voigt J, et al
   Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability.
   Antimicrob Agents Chemother. 2024 Feb 21:e0137323. doi: 10.1128/aac.01373.
   

   >> Share

   
   

   
   Antivir Ther

5. LEPIK KJ, Hunt OL, Bacani N, Wang L, et al
   Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, Canada.
   Antivir Ther. 2024;29:13596535241233128.
   

   >> Share

   
   

   
   J Acquir Immune Defic Syndr

6. GRIESEL R, Banda CG, Zhao Y, Omar Z, et al
   PHARMACOKINETICS OF SINGLE VERSUS DOUBLE-DOSE DOLUTEGRAVIR AFTER SWITCHING FROM A FAILING EFAVIRENZ-BASED REGIMEN.
   J Acquir Immune Defic Syndr. 2024 Feb 15. doi: 10.1097/QAI.0000000000003402.
   

   >> Share

   
   
7. LIEGEON G, Brun A, Hamet G, Zeggagh J, et al
   Incidence and Management of Complex Kidney Situations Among On-demand and Daily HIV Pre-exposure Prophylaxis Users.
   J Acquir Immune Defic Syndr. 2023 Nov 16. doi: 10.1097/QAI.0000000000003346.
   

   >> Share

   
   
8. ARNOLD EM, Kamal S, Rotheram-Borus MJ, Bridges SK, et al
   Factors Associated with Antiretroviral Adherence among Youth Living with HIV.
   J Acquir Immune Defic Syndr. 2023 Nov 17. doi: 10.1097/QAI.0000000000003345.
   

   >> Share

   
   

   
   J Med Virol

9. OMBELET S, Castanares-Zapatero D, Desimpel F, Hulstaert F, et al
   Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron: An updated meta-analysis.
   J Med Virol. 2024;96:e29434.
   

   >> Share

   
   

   
   PLoS One

10. RUNGMAITREE S, Werarak P, Pumpradit W, Phongsamart W, et al
    A pilot program of HIV pre-exposure prophylaxis in Thai youth.
    PLoS One. 2024;19:e0298914.
    

    >> Share

    
    
11. KAMAU SG, Akatusasira R, Namatovu A, Kibet E, et al
    The level of antiretroviral therapy (ART) adherence among orphan children and adolescents living with HIV/AIDS: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0295227.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share